Portfolio of Specialty Pharmaceutical Stocks

Here are 4 specialty pharmaceutical companies.


4 Specialty Pharmaceutical Stocks

Stock Returns & Price Chart

Symbol

Recent Prices &
Annualized Return

AlkermesALKS
BioMarin PharmaceuticalBMRN
Endo InternationalENDP
MallinckrodtMNK
Price data from Quandl as of most recent close.


4 Specialty Pharmaceutical Stocks

Stock Returns & Price Chart

Symbol

Recent Dividends

AlkermesALKS
BioMarin PharmaceuticalBMRN
Endo InternationalENDP
MallinckrodtMNK
Dividend chart data from Quandl as of today.


To inspect the performance of the Specialty Pharmaceutical Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

The 3 stocks included in the portfolio computations are: ALKS, BMRN and ENDP. The current value of the portfolio assumes that $3,333.33 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. MNK was excluded from the portfolio computations because of insufficient price data.

The current value of a $10,000 investment is $22,370. The percent return is 123.70%. The annualized return is 8.38%.



Return Summary for Specialty Pharmaceutical Stocks
Start DateDec-31-2009
Start Investment$10,000.00
End DateDec-06-2019
Current Value of Investment$22,370.09
Total Return123.70%
Annualized Return8.38%
Min DateDec-31-2009
Min Price$10,000.00
Max DateJul-31-2015
Max Price$64,944.28
# Values121
Number Returns7,260
Number Profitable Returns4,977
Percent Profitable Returns68.55%
Number Unprofitable Returns2,283
Percent Unprofitable Returns31.45%
Profitable to Unprofitable Returns Ratio2.18


NOTE: The stocks included in the tables and chart are representative of the industry. They are not recommendations.

Related Portfolios

Portfolio of Biotech Stocks

Portfolio of Dividend-Paying Pharmaceutical Stocks

Portfolio of Generic Drug Stocks